Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures have invested RMB975 million (US$150 million) in CStone Pharmaceuticals Co., Ltd, a bio-pharmaceutical company devoted to developing new treatments for various major diseases.